Higher Prevalence of Extended Spectrum β-Lactamase Producing Uropathogenic Escherichia coli Among Patients with Diabetes from a Tertiary Care Hospital of Kathmandu, Nepal.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Anti-Infective Agents
/ therapeutic use
Child
Child, Preschool
Cross-Sectional Studies
Diabetes Complications
/ drug therapy
Drug Resistance, Multiple, Bacterial
/ drug effects
Escherichia coli Infections
/ drug therapy
Female
Healthy Volunteers
Humans
Infant
Male
Middle Aged
Nepal
/ epidemiology
Prevalence
Sex Factors
Tertiary Care Centers
Urinary Tract Infections
/ drug therapy
Uropathogenic Escherichia coli
/ drug effects
Young Adult
beta-Lactamases
/ genetics
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
23 08 2021
23 08 2021
Historique:
received:
17
06
2021
accepted:
06
07
2021
pubmed:
24
8
2021
medline:
22
2
2022
entrez:
23
8
2021
Statut:
epublish
Résumé
This study aimed to determine the occurrence of antibiotic resistance genes for β-lactamases; blaTEM and blaCTX-M in uropathogenic Escherichia coli isolates from urinary tract infection (UTI) suspected diabetic and nondiabetic patients. A hospital-based cross-sectional study was conducted in Kathmandu Model Hospital, Kathmandu, in association with the Department of Microbiology, GoldenGate International College, Kathmandu, Nepal, from June to December 2018. A total of 1,267 nonduplicate midstream urine specimens were obtained and processed immediately for isolation of uropathogens. The isolates were subjected to antibiotic susceptibility testing and extended spectrum β-lactamase (ESBL) confirmation. In addition, blaTEM and blaCTX-M genes were detected using specific primers. The overall prevalence of UTI was 17.2% (218/1,267), of which patients with diabetes were significantly more infected; 32.3% (31/96) as compared with nonpatients with diabetes, 15.9% (187/1,171). A total of 221 bacterial isolates were obtained from 218 culture-positive specimens in which E. coli was the most predominant; 67.9% (150/221). Forty-four percent (66/150) of the total E. coli was multidrug resistant and 37.3% (56/150) were ESBL producers. Among 56 isolates, 92.3% (12/13) were from patients with diabetes, and 83.0% (44/53) were from nondiabetics. Furthermore, 84.9% of the screened ESBL producers were confirmed to possess either single or both of blaTEM and blaCTX-M genes. The blaTEM and blaCTX-M genes were detected in 53.6% and 87.5% of the phenotypically ESBL confirmed E. coli, respectively. Higher rates of ESBL producing uropathogenic E. coli are associated among patients with diabetes causing an alarming situation for disease management. However, second-line drugs with broad antimicrobial properties are still found to be effective drugs for multidrug resistance strains.
Identifiants
pubmed: 34424860
doi: 10.4269/ajtmh.21-0691
pii: tpmd210691
pmc: PMC8592212
doi:
pii:
Substances chimiques
Anti-Infective Agents
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM